212 related articles for article (PubMed ID: 19911167)
1. Genotoxic effects of the antileishmanial drug Glucantime.
Lima MI; Arruda VO; Alves EV; de Azevedo AP; Monteiro SG; Pereira SR
Arch Toxicol; 2010 Mar; 84(3):227-32. PubMed ID: 19911167
[TBL] [Abstract][Full Text] [Related]
2. Soy isoflavones have antimutagenic activity on DNA damage induced by the antileishmanial Glucantime (meglumine antimoniate).
Cantanhêde LF; Almeida LP; Soares RE; Castelo Branco PV; Pereira SR
Drug Chem Toxicol; 2015; 38(3):312-7. PubMed ID: 25268948
[TBL] [Abstract][Full Text] [Related]
3. Assessment of the in vivo genotoxicity of vanadate: analysis of micronuclei and DNA damage induced in mice by oral exposure.
Leopardi P; Villani P; Cordelli E; Siniscalchi E; Veschetti E; Crebelli R
Toxicol Lett; 2005 Jul; 158(1):39-49. PubMed ID: 15993742
[TBL] [Abstract][Full Text] [Related]
4. Meglumine Antimoniate (Glucantime) Causes Oxidative Stress-Derived DNA Damage in BALB/c Mice Infected by Leishmania (Leishmania) infantum.
Moreira VR; de Jesus LCL; Soares RP; Silva LDM; Pinto BAS; Melo MN; Paes AMA; Pereira SRF
Antimicrob Agents Chemother; 2017 Jun; 61(6):. PubMed ID: 28320726
[TBL] [Abstract][Full Text] [Related]
5. Developmental toxicity of meglumine antimoniate and transplacental transfer of antimony in the rat.
Miranda ES; Miekeley N; De-Carvalho RR; Paumgartten FJ
Reprod Toxicol; 2006 Apr; 21(3):292-300. PubMed ID: 16271447
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of the potential genotoxicity of chromium picolinate in mammalian cells in vivo and in vitro.
Andersson MA; Petersson Grawé KV; Karlsson OM; Abramsson-Zetterberg LA; Hellman BE
Food Chem Toxicol; 2007 Jul; 45(7):1097-106. PubMed ID: 17418471
[TBL] [Abstract][Full Text] [Related]
7. In vivo Comet assay on isolated kidney cells to distinguish genotoxic carcinogens from epigenetic carcinogens or cytotoxic compounds.
Nesslany F; Zennouche N; Simar-Meintières S; Talahari I; Nkili-Mboui EN; Marzin D
Mutat Res; 2007 Jun; 630(1-2):28-41. PubMed ID: 17507283
[TBL] [Abstract][Full Text] [Related]
8. Genotoxicity of nanomaterials: DNA damage and micronuclei induced by carbon nanotubes and graphite nanofibres in human bronchial epithelial cells in vitro.
Lindberg HK; Falck GC; Suhonen S; Vippola M; Vanhala E; Catalán J; Savolainen K; Norppa H
Toxicol Lett; 2009 May; 186(3):166-73. PubMed ID: 19114091
[TBL] [Abstract][Full Text] [Related]
9. Sensitivity to Glucantime of Leishmania viannia isolated from patients prior to treatment.
Robledo SM; Valencia AZ; Saravia NG
J Parasitol; 1999 Apr; 85(2):360-6. PubMed ID: 10219320
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of streptozotocin genotoxicity in rats from different ages using the micronucleus assay.
Vikram A; Tripathi DN; Ramarao P; Jena GB
Regul Toxicol Pharmacol; 2007 Dec; 49(3):238-44. PubMed ID: 17980470
[TBL] [Abstract][Full Text] [Related]
11. Genotoxicity evaluation of dimethoate to experimental mice by micronucleus, chromosome aberration tests, and comet assay.
Ayed-Boussema I; Rjiba K; Mnasri N; Moussa A; Bacha H
Int J Toxicol; 2012; 31(1):78-85. PubMed ID: 21994239
[TBL] [Abstract][Full Text] [Related]
12. Genotoxic effects of (-)-cubebin in somatic cells of mice.
Maistro EL; Natel AV; de Souza GH; Perazzo FF
J Appl Toxicol; 2011 Mar; 31(2):185-9. PubMed ID: 21351285
[TBL] [Abstract][Full Text] [Related]
13. Cytogenetic observations after meglumine antimoniate therapy for visceral leishmaniasis.
Hantson P; Léonard ED; Crutzen-Fayt MC; Léonard A; Vandercam B; Delaere B; Mahieu P
Pharmacotherapy; 1996; 16(5):869-71. PubMed ID: 8888081
[TBL] [Abstract][Full Text] [Related]
14. Genotoxicity assessment of the antimalarial compound artesunate in somatic cells of mice.
Aquino I; Perazzo FF; Maistro EL
Food Chem Toxicol; 2011 Jun; 49(6):1335-9. PubMed ID: 21419820
[TBL] [Abstract][Full Text] [Related]
15. Titanium dioxide nanoparticles trigger p53-mediated damage response in peripheral blood lymphocytes.
Kang SJ; Kim BM; Lee YJ; Chung HW
Environ Mol Mutagen; 2008 Jun; 49(5):399-405. PubMed ID: 18418868
[TBL] [Abstract][Full Text] [Related]
16. Antimony in plasma and skin of patients with cutaneous leishmaniasis--relationship with side effects after treatment with meglumine antimoniate.
Neves DB; Caldas ED; Sampaio RN
Trop Med Int Health; 2009 Dec; 14(12):1515-22. PubMed ID: 19954451
[TBL] [Abstract][Full Text] [Related]
17. Genotoxicity in lead treated human lymphocytes evaluated by micronucleus and comet assays.
Shah AJ; Lakkad BC; Rao MV
Indian J Exp Biol; 2016 Aug; 54(8):502-8. PubMed ID: 28577517
[TBL] [Abstract][Full Text] [Related]
18. Antimony oxidation states in antileishmanial drugs.
Franco MA; Barbosa AC; Rath S; Dorea JG
Am J Trop Med Hyg; 1995 May; 52(5):435-7. PubMed ID: 7771610
[TBL] [Abstract][Full Text] [Related]
19. Genistein and Ascorbic Acid Reduce Oxidative Stress-Derived DNA Damage Induced by the Antileishmanial Meglumine Antimoniate.
de Jesus LCL; Soares RP; Moreira VR; Pontes RL; Castelo-Branco PV; Pereira SRF
Antimicrob Agents Chemother; 2018 Sep; 62(9):. PubMed ID: 29941649
[TBL] [Abstract][Full Text] [Related]
20. An evaluation of the genotoxic and cytotoxic effects of the anti-obesity drugs sibutramine and fenproporex.
da Silva CJ; dos Santos JE; Satie Takahashi C
Hum Exp Toxicol; 2010 Mar; 29(3):187-97. PubMed ID: 20051455
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
